Pilot of Training on 988 and Narcan

NCT ID: NCT07072819

Last Updated: 2025-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

23 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-12

Study Completion Date

2025-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This pilot study evaluates the acceptability, appropriateness, and feasibility of a new crisis response training called Crisis Ready.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study team conducted formative work to develop a new crisis response training for people involved in a law-enforcement assisted diversion program. The training, called Crisis Ready, combines an intervention that aims to promote use of 988 with a training on the use of Naloxone to reverse and overdose. The pilot aims to collect quantitative and qualitative data about the perceptions of the training among program participants and program staff.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Suicide Overdose Accidental Overdose Antidote Crisis Response Plan

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Crisis Ready Training

This is an open label pilot of a new psychoeducational Intervention called the Crisis Ready Training. The intervention combines Crisis Line Facilitation and Take Home Naloxone trainings.

Group Type EXPERIMENTAL

Crisis Ready Training

Intervention Type BEHAVIORAL

Crisis Ready Training combines Crisis Line Facilitation with Take Home Naloxone training. The intervention is delivered in a group format.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Crisis Ready Training

Crisis Ready Training combines Crisis Line Facilitation with Take Home Naloxone training. The intervention is delivered in a group format.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participates in the Baltimore Crisis Response, Inc Law Enforcement Assisted Diversion Program
* Capacity to give informed consent

Exclusion Criteria

* Unable to understand English
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Henry Ford Health + Michigan State University Health Sciences

OTHER

Sponsor Role collaborator

Brown University

OTHER

Sponsor Role collaborator

RAND

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alison Athey

Behavioral Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alison J Athey, PhD

Role: PRINCIPAL_INVESTIGATOR

RAND

Sapna Mendon-Plasek, PhD

Role: PRINCIPAL_INVESTIGATOR

RAND

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Baltimore Crisis Response, Inc.

Baltimore, Maryland, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-N0187

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Rapid Adaptation to Prevent Drug Use
NCT05806840 ACTIVE_NOT_RECRUITING NA